Author
Share this page:
Tag Archives: Fibrosis
Can We Prevent Portal Vein Thrombosis in Patients With Cirrhosis?
The anti-clotting agent enoxaparin prevents portal vein thrombosis (PVT) in patients with cirrhosis, according to the November issue of Gastroenterology. PVT can lead to portal hypertension and reduce the blood supply to the liver—some patients with acute or extensive PVT develop severe gastrointestinal … Continue reading
Differences in HCV Infection, and Effects of Treatment, Among Countries
Hepatitis C virus (HCV) infections have developed and spread at different rates in different countries, affecting outcomes of therapy, according to the October issue of Gastroenterology. Specific details of each population must therefore be considered in designing prevention and treatment … Continue reading
Posted in Basic Science, Practice
Tagged Cirrhosis, disease progression, Epidemiology, Europe, Fibrosis, hepatitis, Liver Cancer, liver disease, transplant, United States
Leave a comment
How Common is Portal Hypertension in Patients With NAFLD?
Patients with nonalcoholic fatty liver disease (NAFLD) are at risk for portal hypertension and esophageal varices, according to the September issue of Clinical Gastroenterology and Hepatology. The study also shows that factors such as advanced liver disease, type 2 diabetes, … Continue reading
Posted in Practice
Tagged Cirrhosis, disease progression, fatty liver disease, Fibrosis, Inflammation, liver disease, NAFLD, NASH, Obesity, Prevention, risk factor
2 Comments
What Factors Predict Recovery From Chronic HBV Infection?
A low and rapidly decreasing level of Hepatitis B surface antigen (HBsAg) is a good sign for patients with chronic HBV infection, according to the March issue of Clinical Gastroenterology and Hepatology. Tracking progression of chronic HBV infection can be … Continue reading
Can We Treat Chronic HCV Infection Without Interferon?
A potent combination of 2 drugs that directly target the hepatitis C virus (HCV) is effective in patients with chronic infection, and doesn’t require interferon therapy, according to an article in the December issue of Gastroenterology. Patients infected with HCV … Continue reading
Posted in Practice
Tagged Cirrhosis, Clinical Trial, DAA, direct acting antiviral agent, drug development, Fibrosis, HCV, hepatitis C, liver disease, therapy
1 Comment
As Incidence of HCV Infection Increases, a New Mouse Model to Study
The incidence of hepatitis C virus (HCV) infection and its complications—hepatocellular carcinoma (HCC) and cirrhosis—are increasing, according to Fasiha Kanwal et al. Fortunately, a new mouse model has been created to study disease progression and treatment, as described by Michael … Continue reading
Posted in Basic Science, Practice
Tagged Animal Model of Hepatitis, Cancer, Epidemiology, Fibrosis, Human Immunology, Virology
Leave a comment
Kristine Novak, PhD, Science Editor
